References
- Negrato CA, Mattar R, Gomes MB. Adverse pregnancy outcomes in women with diabetes. Diabetol Metab Syndr. 2012;4(1):41.
- Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care. 2009;32(11):2005–2009.
- Eidem I, Stene LC, Henriksen T, et al. Congenital anomalies in newborns of women with type 1 diabetes: nationwide population-based study in Norway, 1999–2004. Acta Obstet Gynecol Scand. 2010;89(11):1403–1411.
- Eidem I, Vangen S, Hanssen KF, et al. Perinatal and infant mortality in term and preterm births among women with type 1 diabetes. Diabetologia. 2011;54(11):2771–2778.
- Clausen TD, Mathiesen E, Ekbom P, et al. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care. 2005;28(2):323–328.
- Kulshrestha V, Agarwal N. Maternal complications in pregnancy with diabetes. J Pak Med Assoc. 2016;66(9 Suppl. 1):S74–S77.
- Maresh MJA, Holmes VA, Patterson CC, et al. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care. 2015;38(1):34–42.
- Gutaj P, Zawiejska A, Mantaj U, et al. Determinants of preeclampsia in women with type 1 diabetes. Acta Diabetol. 2017;54(12):1115–1121.
- Dunne F, Brydon P, Smith K, et al. Pregnancy in women with type 2 diabetes: 12 years outcome data 1990–2002. Diabet Med. 2003;20(9):734–738.
- National Health Service (NHS) Digital. National Pregnancy In Diabetes Annual Report 2016; 2016; [cited 2019 Mar 12]. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/national-pregnancy-in-diabetes-audit/national-pregnancy-in-diabetes-annual-report-2016#key-facts
- Yu H, Qi X, Wang X. Application of glycated hemoglobin in the perinatal period. Int J Clin Exp Med. 2014;7(12):4653–4659.
- Yan P, Wang Y, Yu X, et al. Maternal diabetes and risk of childhood malignancies in the offspring: a systematic review and meta-analysis of observational studies. Acta Diabetol. 2020;58(2):153–168.
- Sesmilo G, Prats P, Garcia S, et al. First-trimester fasting glycemia as a predictor of gestational diabetes (GDM) and adverse pregnancy outcomes. Acta Diabetol. 2020;57(6):697–703.
- Egan AM, Galjaard S, Maresh MJA, et al. A core outcome set for studies evaluating the effectiveness of prepregnancy care for women with pregestational diabetes. Diabetologia. 2017;60(7):1190–1196.
- American Diabetes Association. 14. Management of diabetes in pregnancy: standards of medical care in diabetes-2019. Diabetes Care. 2019;42:S165–S172.
- Stubert J, Reister F, Hartmann S, et al. The risks associated with obesity in pregnancy. Dtsch Arztebl Int. 2018;115:276–283.
- Cosson E, Cussac-Pillegand C, Benbara A, et al. Pregnancy adverse outcomes related to pregravid body mass index and gestational weight gain, according to the presence or not of gestational diabetes mellitus: a retrospective observational study. Diabetes Metab. 2016;42(1):38–46.
- English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control. 2015;8:7–12.
- De-Regil LM, Pena-Rosas JP, Fernandez-Gaxiola AC, et al. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2015;CD007950.
- National Institute for Health and Care Excellence. NICE guideline [NG3]: diabetes in pregnancy: management from preconception to the postnatal period; 2015; [cited 2019 Mar 12]. Available from: https://www.nice.org.uk/guidance/ng3
- Chitayat D, Matsui D, Amitai Y, et al. Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update. J Clin Pharmacol. 2016;56(2):170–175.
- Mathiesen ER, Ringholm L, Feldt-Rasmussen B, et al. Obstetric nephrology: pregnancy in women with diabetic nephropathy—the role of antihypertensive treatment. Clin J Am Soc Nephrol. 2012;7(12):2081–2088.
- Antza C, Cifkova R, Kotsis V. Hypertensive complications of pregnancy: a clinical overview. Metabolism. 2018;86:102–111.
- Giacobbe AM, Grasso R, Triolo O, et al. Thyroid diseases in pregnancy: a current and controversial topic on diagnosis and treatment over the past 20 years. Arch Gynecol Obstet. 2015;292(5):995–1002.
- Mongan D, Lynch J, Hanna D, et al. Prevalence of self-reported mental disorders in pregnancy and associations with adverse neonatal outcomes: a population-based cross-sectional study. BMC Pregnancy Childbirth. 2019;19(1):412.
- Bonham CA, Patterson KC, Strek ME. Asthma outcomes and management during pregnancy. Chest. 2018;153(2):515–527.
- Mathiesen ER, Andersen H, Kring SI, et al. Design and rationale of a large, international, prospective cohort study to evaluate the occurrence of malformations and perinatal/neonatal death using insulin detemir in pregnant women with diabetes in comparison with other long-acting insulins. BMC Pregnancy Childbirth. 2017;17(1):38.
- Li Y, Wang W, Zhang D. Maternal diabetes mellitus and risk of neonatal respiratory distress syndrome: a meta-analysis. Acta Diabetol. 2019;56(7):729–740.
- Cawley S, Mullaney L, McKeating A, et al. A review of European guidelines on periconceptional folic acid supplementation. Eur J Clin Nutr. 2016;70(2):143–154.
- Gomes S, Lopes C, Pinto E. Folate and folic acid in the periconceptional period: recommendations from official health organizations in thirty-six countries worldwide and WHO. Public Health Nutr. 2016;19(1):176–189.
- Vitale K, Mujkic A, Todorovic G, et al. Is level of knowledge, attitude and use of folic acid among pregnant women in Croatia a call for public health action? Period Biol. 2009;111:329–335.
- Murphy HR, Bell R, Cartwright C, et al. Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study. Diabetologia. 2017;60(9):1668–1677.
- Tirosh D, Benshalom-Tirosh N, Novack L, et al. Hypothyroidism and diabetes mellitus – a risky dual gestational endocrinopathy. PeerJ. 2013;1:e52.
- Nguyen CT, Sasso EB, Barton L, et al. Graves' hyperthyroidism in pregnancy: a clinical review. Clin Diabetes Endocrinol. 2018;4:4.
- Zhou M, Wang M, Li J, et al. Effects of thyroid diseases on pregnancy outcomes. Exp Ther Med. 2019;18:1807–1815.
- Coton SJ, Nazareth I, Petersen I. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012. BMJ Open. 2016;6(1):e009494.
- Landsberg L, Molitch M. Diabetes and hypertension: pathogenesis, prevention and treatment. Clin Exp Hypertens (New York, NY: 1993). 2004;26(7–8):621–628.
- Bramham K, Parnell B, Nelson-Piercy C, et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ (Clinical Research ed). 2014;348(7):g2301.
- Nakhai-Pour HR, Rey E, Berard A. Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns. Birth Defects Res B Dev Reprod Toxicol. 2010;89:147–154.
- Garne E, Vinkel Hansen A, Morris J, et al. Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy – a cohort linkage study. BJOG. 2016;123(10):1609–1618.
- Tomson T, Xue H, Battino D. Major congenital malformations in children of women with epilepsy. Seizure. 2015;28:46–50.
- Bérard A, Zhao JP, Sheehy O. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ Open. 2017;7(1):e013372.
- Vargas R, Repke JT, Ural SH. Type 1 diabetes mellitus and pregnancy. Rev Obstet Gynecol. 2010;3:92–100.